Cognition Therapeutics In...
(CGTX)
undefined
undefined%
At close: undefined
0.47
-4.24%
Pre-market Dec 16, 2024, 04:48 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -25.79M | -21.40M | -11.72M | -7.84M | -4.84M |
| Depreciation & Amortization | 252.00K | 235.00K | 93.00K | 98.00K | 81.00K |
| Stock-Based Compensation | 4.35M | 3.57K | 5.18K | 475.00 | 361.00 |
| Other Working Capital | 2.46M | 149.00K | 677.00K | 3.43M | -292.00K |
| Other Non-Cash Items | 318.00K | 6.54M | 383.00K | 836.00K | 494.00K |
| Deferred Income Tax | - | -6.54M | -416.00K | -70.00K | 238.00K |
| Change in Working Capital | 4.85M | -943.00K | 2.84M | 3.07M | 570.00K |
| Operating Cash Flow | -16.02M | -18.53M | -3.63M | -3.43M | -3.10M |
| Capital Expenditures | -147.00K | -171.00K | -27.00K | -10.00K | -144.00K |
| Acquisitions | - | - | - | - | - |
| Purchase of Investments | - | - | - | - | - |
| Sales Maturities Of Investments | - | - | - | - | - |
| Other Investing Acitivies | - | -171.00K | -27.00K | - | - |
| Investing Cash Flow | -147.00K | -171.00K | -27.00K | -10.00K | -144.00K |
| Debt Repayment | -811.00K | -1.40M | -268.00K | 5.81M | 2.83M |
| Common Stock Repurchased | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - |
| Other Financial Acitivies | - | 1.62M | 9.25M | -46.00K | -34.00K |
| Financial Cash Flow | 4.52M | 5.55M | 53.20M | 5.76M | 2.79M |
| Net Cash Flow | -11.64M | -13.16M | 49.53M | 2.30M | -508.00K |
| Free Cash Flow | -16.16M | -18.70M | -3.66M | -3.44M | -3.24M |